Skip to main content
Abnova logo

Abnova — Investor Relations & Filings

Ticker · 4133 ISIN · TW0004133004 TW Professional, scientific and technical activities
Open in API
Filings indexed 1,483 across all filing types
Latest filing 2015-09-09 Regulatory Filings
Country TW Taiwan
Listing TW 4133

About Abnova

http://www.abnova.com

Abnova Corporation is a global leader in the high-throughput production of antibodies and recombinant proteins. By integrating industrial-scale manufacturing with IT-driven management systems, the company maintains one of the world's largest catalogs of biological reagents. Its core offerings encompass gene synthesis, cytogenetics, peptide services, and protein expression. Abnova provides comprehensive solutions for life science research, including custom antibody production, scale-up, and humanization. Recent technological expansions include the RNAutomation™ mRNA service, NanoAb™ services, and nanoCAR-T mRNA solutions. The company supports academic and industrial researchers across multidisciplinary fields with integrated assay development and advanced bioreagent tools.

Recent filings

Filing Released Lang Actions
104年8月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a company named 亞諾法, providing data on fund lending balances and endorsement guarantees for a specific month (August of the 104th year in the Taiwanese calendar, which corresponds to 2015). The content is very short (610 characters) and consists mainly of tabular financial data without detailed analysis or narrative. It does not contain comprehensive financial statements or management discussion. It appears to be a regulatory disclosure or compliance update rather than a full report. Given the short length and nature of the content, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2015-09-09 Chinese
104年08月董事會成員及持股
Major Shareholding Notification Classification · 95% confidence The document contains detailed tabular data about shareholdings of company insiders, including directors, supervisors, and executives, with specific numbers of shares held, pledged shares, and related percentages. It is a disclosure of insider shareholdings and changes, typical of a Director's Dealing or insider shareholding notification. The document is relatively short (3241 characters) and does not contain financial statements or management discussion. It is not an announcement of voting results, nor a general regulatory filing. The content matches the definition of Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels or insider holdings. Therefore, the appropriate classification is MRQ.
2015-09-08 Chinese
104年08月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document consists of detailed tables listing shareholdings of company insiders, including directors, supervisors, and senior management, with specific stock counts and changes. It focuses on insider share ownership and transactions, showing monthly increases and decreases in holdings. There is no indication of financial statements, earnings data, or management discussion. The content aligns with reporting of personal share transactions by company directors and executives, which fits the definition of Director's Dealing (DIRS). The document length is substantial and contains actual data, not just an announcement or certification. Therefore, the appropriate classification is DIRS.
2015-09-08 Chinese
更正本公司104年第二季XBRL註銷股本股數
Regulatory Filings Classification · 95% confidence The document is a short announcement from a company (亞諾法生技股份有限公司) correcting previously reported data regarding the cancellation of shares in the second quarter of the year 104 (Taiwan calendar, equivalent to 2015). The document is only 617 characters long and primarily states a correction and re-upload of data to the public information observation station. There is no detailed financial data, no full report, no financial statements, and no presentation materials. It is a regulatory announcement correcting previously submitted data. According to the rules, short announcements correcting or updating filings without substantive financial data or report content should be classified as Regulatory Filings (RNS).
2015-08-14 Chinese
104年第2季資產負債表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated balance sheet with detailed financial data for multiple periods, including specific asset, liability, and equity line items with amounts and percentages. The data is presented for the second quarter of the 104th year (likely referring to a fiscal quarter) and includes comparative figures from previous periods. The document length is 3555 characters, which is relatively short but contains substantive financial data rather than just an announcement or a link to a report. The presence of detailed financial statements for a quarter indicates this is a financial report for a period shorter than a full fiscal year. Therefore, this document fits the definition of an Interim / Quarterly Report (IR).
2015-08-14 Chinese
104年第2季綜合損益表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated comprehensive income statement with detailed financial data for the second quarter and half-year periods of the fiscal year 104 (Taiwan calendar, corresponding to 2015). It includes revenue, costs, expenses, net income, and earnings per share figures. The presence of actual financial statements and substantive financial data for a period shorter than a full fiscal year indicates this is a quarterly or interim financial report. The document length is about 3035 characters, which is sufficient to contain financial data, not just an announcement or certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR).
2015-08-14 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.